## Autoimmune Treatments
To date, besides some exceptions, autoimmune diseases cannot be cured, only treated.

This repo attempts to compile the current treatments for autoimmune diseases as well as possible cures. Notes and literature sources are included.


#### 1. Cell Depletion
* B Cell
	* Antibody
		* CD-20 - ***not expressed by plasma cells***
			* Rituximab (Rituxan)
				* SLE
					* https://pubmed.ncbi.nlm.nih.gov/20039413/ **(no difference compared to placebo)**
				* Sjögren syndrome
					* https://pubmed.ncbi.nlm.nih.gov/24727841/ **(some fatigue improvement early)**
					* https://pubmed.ncbi.nlm.nih.gov/28296257/ **(no difference compared to placebo)**
				* Immune thrombocytopenia
					* https://pubmed.ncbi.nlm.nih.gov/22223819/ **(no difference compared to placebo)**
			* Ocrelizumab (Ocrevus)
				* Multiple Sclerosis
					* https://pubmed.ncbi.nlm.nih.gov/28002688/ **(lower rates of disease and MRI progression compared to placebo)**
					* https://pubmed.ncbi.nlm.nih.gov/28002679/ **(lower rates of disease and progression compared to interferon beta-1a)**
				* Autoimmune Encephalitis
					* https://pubmed.ncbi.nlm.nih.gov/35129803/ **(did not meet recruitment goals)**
			* Obinutuzumab (Gazyva)
				* **No RCTs for autoimmunity.**
			* Ofatumumab (Kesimpta)
				* Multiple Sclerosis
					* https://www.nejm.org/doi/full/10.1056/NEJMoa1917246 **(lower relapse rates than teriflunomide treatment)**
					* https://pubmed.ncbi.nlm.nih.gov/29695594/ **(demonstrated efficacy)**
				* Rheumatoid Arthritis
					* https://pubmed.ncbi.nlm.nih.gov/20506254/ **(clinically effective)**
		* CD-19 - ***also expressed by plasma cells***
			* Loncastuximab tesirine (Zynlonta)
			* Tafasitamab (Monjuvi)
			* Blinatumomab (Blincyto) - ***targets CD3 as well***
		* BAFF (B-cell activating factor)
			* Belimumab (Benlysta)
	* CAR-T Therapy
	    * CD-19
	    	* https://pubmed.ncbi.nlm.nih.gov/36109639/ **(complete remission in all 5 patients with severe SLE after 1 year follow-up) (!)**
	    * BCMA (B cell maturation antigen)
* T Cell
	* Antibody
		* CD3ε
			* Muromonab-CD3 (Orthoclone OKT3)

#### 2. Cellular Inhibition
* Corticosteroids
	* Prednisone
	* Methylprednisone
	* Dexamethasone
	* Hydrocortisone
	* Budesonide (Pulmicort)
* JAK (Janus kinase) Inhibitors
	* Tofacitinib (Xeljanz)
	* Upadacitinib (Rinvoq)
	* Abrocitinib (Cibinqo)
	* Baricitinib (Olumiant)
	* Filgotinib (Jyseleca)
	* Ruxolitinib (Jakafi / Jakavi)
	* Peficitinib (Smyraf)
	* Pacritinib (Vonjo)
	* Oclacitinib (Apoquel)
	* Fedratinib (Inrebic)
	* Delgocitinib (Corectim)
* Purine Synthesis Inhibitors
	* Azathioprione (Imuran)
	* Mycophenolic acid (CellCept)
	* Mercaptopurine (Purinethol)
* Pyrimidine Synthesis Inhibitors
	* Fluorouracil (Adrucil)
	* Teriflunomide (Aubagio)
	* Leflunomide (Arava)
* Calcineurin Inhibitors
	* Tacrolimus (Prograf)
	* Ciclosporin
* mTOR inhibitors
	* Rapamycin (Sirolimus)
	* Temsirolimus (Torisel)
	* Everolimus (Afinitor)
	* Ridaforolimus
	* Umirolimus (Biolimus)
	* Zotarolimus
* Other
	* Cyclophosphamide - **alkylating mustard agent**
	* Methotrexate (MTX) - **dihydrofolate reductase inhibitor**
	* Fingolimod (Gilenya) - **sphingosine-1-phosphate receptor modulator**
	* Myriocin (ISP-1 / thermozymocidin) - **serine palmitoyltransferase inhibitor**


#### 3. Cytokine Inhibition
* Interferon type I
* TNFα
* IL-1
* IL-4
* IL-5
* IL-6
* IL-12
* IL-13
* IL-17
* IL-23


#### 4. Cytokine Therapy
* IL-10
* IL-35


#### 5. Antibody Reduction
* Plasmapharesis
* IVIg (intravenous immunoglobulin)


#### 6. HSC Transplantation


#### 7. Microbiome Alteration
https://pubmed.ncbi.nlm.nih.gov/35534624/


#### 8. T<sub>reg</sub> Engineering
